[Metabolic syndrome]
Kazuaki Shimamoto1, Tetsuji Miura
1Second Department of Internal Medicine, Sapporo Medical University School of Medicine.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|April 8, 2009
Summary
Angiotensin II worsens insulin resistance by disrupting adipocyte function and promoting inflammation. Angiotensin Receptor Blockers (ARBs) improve insulin sensitivity by restoring adipokine balance, suggesting a therapeutic role.
Area of Science:
- Endocrinology
- Metabolic Syndrome Research
- Molecular Biology
Background:
- Insulin resistance is a key feature of metabolic syndrome.
- Adipokines like adiponectin and TNF-alpha play critical roles in regulating insulin sensitivity.
- Angiotensin II is implicated in the pathogenesis of insulin resistance.
Purpose of the Study:
- To investigate the role of Angiotensin II in modulating adipocytokines and insulin sensitivity.
- To explore the effects of Angiotensin Receptor Blockers (ARBs) on adipocytokine profiles and insulin resistance.
Main Methods:
- Examined the effects of Angiotensin II on insulin receptor and IRS-1 phosphorylation.
- Assessed the impact of Angiotensin II on adipocyte differentiation and adipokine production (adiponectin, TNF-alpha).
- Evaluated the influence of ARBs on adiponectin and TNF-alpha levels and insulin sensitivity.
Main Results:
- Angiotensin II impairs insulin sensitivity by altering insulin receptor and IRS-1 signaling.
- Angiotensin II suppresses adiponectin and promotes TNF-alpha production, particularly in larger adipocytes.
- ARBs were shown to increase adiponectin and decrease TNF-alpha, correlating with improved insulin resistance.
Conclusions:
- Dysfunctional adipocytokines, driven by Angiotensin II, are central to insulin resistance.
- ARBs may improve insulin resistance by correcting adipocytokine imbalances.
- Targeting adipocytokine pathways offers a potential therapeutic strategy for metabolic syndrome.
Related Concept Videos
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:24Overview of Lipid Metabolism
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
01:19Overview of Carbohydrate Metabolism
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
01:21Hyperosmolar Hyperglycemic State
Hyperosmolar Hyperglycemic State, or HHS, is a serious and life-threatening complication of type 2 diabetes mellitus. It is characterized by three main features: severe hyperglycemia, profound dehydration, and elevated serum osmolality, all occurring without significant ketoacidosis.HHS typically develops in older adults or individuals with limited access to fluids. This may result from illness, cognitive impairment, or medications such as diuretics or corticosteroids. These factors reduce...